IRhythm Technologies Inc (IRTC)
iRhythm Technologies Inc. is a healthcare company listed on NASDAQ under the ticker IRTC. Through its digital cardiac monitoring platform, the company designs, develops, and commercializes device-based technology used to diagnose arrhythmias in the United States. Its portfolio includes Zio ambulatory cardiac monitoring services, which cover long-term and short-term continuous monitoring as well as mobile cardiac telemetry. The company also provides prescription-only remote ECG systems such as Zio Monitor, Zio XT, and Zio AT, along with software designed to capture and analyze ECG data. iRhythm has also entered into a development collaboration with BioIS focused on pulse oximetry, accelerometry, and non-invasive blood pressure technologies for use in ambulatory cardiac monitoring products and services. The company was incorporated in 2006 and is headquartered in San Francisco, California.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-IRTC
|
$91.76
|
-16.9% Downside
|
Fair
|
$178.38
|
61.6% Upside
|
Bargain
|
Good
|
—
|
—
|
—
|
0.0%
|
August 6, 2026
|
-131.1x
|
22.6x
|
4.6x
|
3.66 B
|
3.749 B
|
16.6%
|
93.7%
|
2.8
|
—
|
-67.5%
|
